Course Summary
One of the most challenging issues health clinicians can face is a patient’s suicidal crisis. Yet, suicidality is often not a component of clinical training. The following three main sections of Suicide Prevention – Part 1 Prevalence, Trends and Theories of Suicidology, Part 2 Assessment, Risk Factors, and Diagnosis of Suicidality, and Part 3 Psychotherapy, Pharmacology, and Brain Stimulation Treatments for Suicidal Patients – will highlight the prevalence of suicide, varied guidelines on suicide risk assessment generally and in special populations, and options for therapy aimed at the prevention of suicidal behavior. This course will include the use of inpatient and outpatient programs that promote recovery and healing for suicidal patients and families.
Course Format
Homestudy
Learning Objectives
- To provide health clinicians with knowledge of the guidelines on suicide assessment, treatment and prevention for individuals of all age groups, taking into consideration risk factors and high-risk population groups.
Course Syllabus
- Introduction
- PART 1: Prevalence, Trends and Theories of Suicidology
- Prevalence of Suicide
- Trends on Suicide – CDC Data
- Trends on Suicide – Global Data
- Theories and Research on Suicide Prevention
- Part 2: Assessment, Risk Factors, and Diagnosis of Suicidality
- Assessment of Suicidality
- Terminology for Assessment of Suicidal Behavior
- Misconceptions of Suicidal Thoughts/Behaviors
- Goals of Patient Assessment
- Risk Factors for Suicide
- Determination of Suicide Level of Risk
- Multi-Association Suicide Assessment Guidelines
- Identifying Psychiatric Disorder
- Biological or Genetic Suicide Risk Factors
- Psychological and Sociological Risk Factors
- Suicide Risk in Special Populations
- Lesbian, Gay, Bisexual and Transgender
- Childhood Sexual Abuse Victims
- Elderly
- Adolescents
- Unhoused and Inmates
- Physicians
- Culture and Ethnicity: Suicide Risk
- Native Americans/Alaska Natives
- African Americans
- Hispanic/Latinos
- Asian Americans
- Immigrants
- Veterans
- Mental Health Diagnoses and Suicide
- Mood Disorders
- Substance Use Disorders and Pathological Gambling
- Schizophrenia
- Anxiety and Sleep Disorders
- Exposure to Violence and Trauma
- Borderline Personality and Eating Disorders
- Traumatic Brain Injury and Emotional Dysregulation
- Stigma Associated with Psychiatric Disorders
- Part 3: Psychotherapy, Pharmacology and Brain Stimulation Treatments for Suicidal Patients
- Outpatient Treatment
- Case Study: Drug-induced Suicide Attempt
- Psychotherapy Models
- Collaborative Assessment and Management of Suicidality
- Cognitive Behavioral Therapy
- Dialectical Behavioral Therapy
- Alliance-Based Therapy
- Case Study: DBT in a Female with Suicidal Tendencies
- Psychotherapy
- Pharmacological Treatment
- Discussion
- Pharmacology Treatment for Suicidal Patients
- Lithium
- Clozapine
- Ketamine, Antidepressants, Antipsychotics
- Case Studies: Clozapine and Suicidality
- Discussion
- Brain Stimulation Therapies
- Electroconvulsive Therapy
- Transcranial Magnetic Stimulation
- Brain Stimulation Therapies and Lithium
- Case Study: Major Depression, ECT and ECT Side Effects
- Discussion
- Vagus Nerve Stimulation
Authors
Dana Bartlett, RN, BSN, MSN, MA, CSPI
Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 27 years as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, textbook chapters, and more than 100 online CE articles, and done editing and reviewing for publishers such as Elsevier, Lippincott, and Thieme. He has written widely on the subject of toxicology and was a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center. He lives in Wappingers Falls, NY.
Lys Hunt, MSW, LICSW
Lys Hunt, MSW, LICSW earned her Master’s Degree from the Boston University School of Social Work and completed intensive postgraduate programs in family therapy and couples therapy through the Family Institute of Cambridge. Following these programs, she completed a post-graduate fellowship at Boston Children’s Hospital in the department of child and adolescent psychiatry. Throughout her years of experience, Lys provided clinical services and supervision at both the Arbour-Choate Hospital in Massachusetts and the Massachusetts Society for the Prevention of Cruelty to Children. Her current clinical work specializes in the areas of mental health and child and family welfare.
Kellie Wilson, PharmD
Kellie Wilson is a Doctor of Pharmacy practicing in Anaconda, Montana, where she lives with her husband and four children. She attended the University of Montana in Missoula where she graduated in 2009 with a doctorate in pharmacy. She later worked in Boise, Idaho for a large, retail pharmacy for 2 years, and then returned home to Montana to oversee an independently owned retail and long-term care pharmacy in Anaconda. As an independent retail pharmacist she has become very involved in psychiatric pharmacy for two major behavioral health organizations that are located around all of Montana. Kellie’s passion is retail pharmacy because she enjoys the interactions with customers as well as the challenges and rewards of staying current with the continuous changes in the pharmacy field.
